Opportunities and challenges for human papillomavirus vaccination in cancer

Nature Reviews Cancer 18, 240 (2018). doi:10.1038/nrc.2018.13 Authors: Richard B. S. Roden & Peter L. Stern The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV) initiated a quarter century of laboratory and epidemiological studies that demonstrated their necessary, but not sufficient, aetiological role in cervical and several other anogenital and oropharyngeal cancers. Early virus-induced immune deviation can lead
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Review Source Type: research